1. Home
  2. GPMT vs NXTC Comparison

GPMT vs NXTC Comparison

Compare GPMT & NXTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Granite Point Mortgage Trust Inc.

GPMT

Granite Point Mortgage Trust Inc.

N/A

Current Price

$3.33

Market Cap

24.5M

Sector

Real Estate

ML Signal

N/A

Logo NextCure Inc.

NXTC

NextCure Inc.

N/A

Current Price

$5.43

Market Cap

24.8M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
GPMT
NXTC
Founded
2015
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
24.5M
24.8M
IPO Year
2017
2019

Fundamental Metrics

Financial Performance
Metric
GPMT
NXTC
Price
$3.33
$5.43
Analyst Decision
Hold
Strong Buy
Analyst Count
4
3
Target Price
$11.50
★ $20.00
AVG Volume (30 Days)
43.1K
★ 58.6K
Earning Date
11-04-2026
11-17-2026
Dividend Yield
★ 10.72%
N/A
EPS Growth
★ 73.58
N/A
EPS
N/A
★ N/A
Revenue
N/A
★ $22,378,000.00
Revenue This Year
$308.40
N/A
Revenue Next Year
$9.66
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.74
$1.55
52 Week High
$7.61
$15.74

Technical Indicators

Market Signals
Indicator
GPMT
NXTC
Relative Strength Index (RSI) 40.14 43.98
Support Level $1.39 $4.28
Resistance Level $7.61 $6.66
Average True Range (ATR) 0.34 0.78
MACD -0.28 -0.05
Stochastic Oscillator 0.85 33.36

Price Performance

Historical Comparison
GPMT
NXTC

About GPMT Granite Point Mortgage Trust Inc.

Granite Point Mortgage Trust Inc focuses on directly originating, investing in, and managing senior floating rate commercial mortgage loans and other debt and debt-like commercial real estate investments. The company constructs its investment portfolio on a loan-by-loan basis, emphasizing rigorous credit underwriting, selectivity, and diversification, and assesses each investment from a fundamental value perspective relative to other opportunities available in the market. It typically provides intermediate-term bridge or transitional financing for a variety of purposes, including acquisitions, recapitalizations, refinancing, and a range of business plans, including lease-up, renovation, repositioning and repurposing of the commercial property.

About NXTC NextCure Inc.

NextCure Inc is a clinical-stage biopharmaceutical company that is focused on advancing inventive medicines that treat cancer patients that do not respond to, or that have disease progression on, current therapies, through the use of targeted therapies including antibody-drug conjugates. The company's product candidates include NC410 a fusion protein of LAIR-2, a fusion protein that, in combination with pembrolizumab, demonstrated early evidence of clinical activity in colorectal (CRC) and ovarian cancers, and LNCB74, an ADC that is directed to B7-H4, a clinically validated cancer target. The company is also seeking a partner for its other clinical programs such as NC525 and NC318 and its preclinical non-oncology programs NC605, for chronic bone diseases and NC181, for Alzheimer's disease.

Share on Social Networks: